Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the<sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer

Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the<sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer

PET/CT with the new <sup>68</sup>Ga-labeled minigastrin analog DOTA-dGlu-Ala-Tyr-Gly-Trp-(<i>N</i>-Me)Nle-Asp-1-Nal-NH<sub>2</sub> (<sup>68</sup>Ga-DOTA-MGS5) was performed on patients with advanced medullary thyroid cancer (MTC) to evaluate cholecysto...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Elisabeth von Guggenberg, Christian Uprimny, Maximilian Klinger, Boris Warwitz, Anna Sviridenko, Steffen Bayerschmidt, Gianpaolo di Santo, Irene Virgolini
Médium: Artigo
Jazyk:angličtina
Vydáno: 2023
On-line přístup:https://doi.org/10.2967/jnumed.122.264977
https://jnm.snmjournals.org/content/jnumed/64/6/859.full.pdf
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://doi.org/10.2967/jnumed.122.264977
https://jnm.snmjournals.org/content/jnumed/64/6/859.full.pdf

Podobné jednotky